Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
June 18, 2025
How a patient’s stroke led to discovering cancer
Proton therapy was the best treatment choice for patient with lung cancer
Fred Hutch study finds genetic driver of drug resistance in small cell lung cancer
Researchers use CRISPR-Cas9 gene-editing tool on tumor cells grown in mice to better model how tumors that initially respond to chemotherapy become resistant
Tricking cells into trashing cancer
Fred Hutch chemical biologist rapidly reduces lung tumors in mice with a tagging system that grabs cancer-causing proteins and hauls them out with the molecular trash
Encouraged by a physician he saw in the Philippines, stage 3 lung cancer patient turned to Fred Hutch
Proton therapy was the right treatment plan for Gerardo Bada
Cigarettes or vapes, pick your poison
From the Fong Lab, Translational Sciences & Therapeutics Division
20 years since Fred Hutch president helped make EGFR discovery, woman with stage 4 lung cancer is thriving
Dr. Tom Lynch described how targeted therapies could dramatically improve patient outcomes
More to brain tumors than meets the eye
Fred Hutch researchers find new way to classify tumors based on their underlying biology rather than how they look
For a fourth bout of cancer – of the lung this time – Art turned to proton therapy
After three bouts with lymphoma, Art now faced lung cancer.
Science Says: The promise of precision medicine
How understanding unique traits of individuals and their cancers can lead to precise treatments
When more is more: Increased levels of wild-type and mutant RIT1 promote oncogenesis
From the Berger Lab, Human Biology Division